Mikael Dolsten - 15 Dec 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
President R&D
Signature
Susan E. Grant, by power of atty., for Mikael Dolsten
Issuer symbol
PFE
Transactions as of
15 Dec 2023
Transactions value $
$1,000,010
Form type
4
Filing time
19 Dec 2023, 16:37:40 UTC
Previous filing
20 Mar 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $1,000,009 +37,552 +75% $26.63 87,581 15 Dec 2023 Common Stock 37,552 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Deferred Compensation Plan.
F3 The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.